ProCE Banner Activity

Managing Patients With MM After First Relapse: Current Treatment Options and Sequencing

Slideset Download
Download this slideset based on the content from a live-stream CCO series from Paul G. Richardson on treatment options for patients with relapsed/refractory multiple myeloma who have relapsed after first-line therapy.

Released: June 23, 2021

Expiration: June 22, 2022

No longer available for credit.

Share

Faculty

Paul G. Richardson

Paul G. Richardson, MD

Associate Professor of Medicine
Harvard Medical School
Clinical Director
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

GlaxoSmithKline

Karyopharm

Oncopeptides

Sanofi Genzyme

Program Director Disclosure

Program Director

Paul G. Richardson, MD

Associate Professor of Medicine
Harvard Medical School
Clinical Director
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, Massachusetts